Effect of Clinical Crown Lengthening Surgery and Botulinum Toxin A Injection in Gummy Smile Treatment

Sponsor
University of Medicine and Pharmacy at Ho Chi Minh City (Other)
Overall Status
Completed
CT.gov ID
NCT05057286
Collaborator
(none)
20
1
1
10
2

Study Details

Study Description

Brief Summary

Background: The demand for beauty is increasing in society as everyone is looking for cosmetic improvement, including gummy smile correction.

Object: This study aims to evaluate the efficacy of a combination of a clinical tooth crowns lengthening surgery following by a BTX-A injection in gummy smile treatment upon based on clinical assessment and photography

Method: An uncontrolled longitudinal study was implemented at the Faculty of Odonto-Stomatology (FOS) of the University of Medicine and Pharmacy at Ho Chi Minh City (UMPH), Viet Nam, from August 2020 to May 2021. Twenty patients (19 females and one male) at a mean age of 24 years old who came for gummy smile chief complaint were included in the study. Subjects were operated to lengthen the clinical crown following an additional botulinum toxin A injection two months post-surgery. All the participants answered the smile esthetic satisfactory questions and were photographed at the time before treatment (T0), two months after clinical crown lengthening surgery (T1), two weeks (T2), and two months (T3) follow-up visits after BTX-A injection. The gingival exposure (GE) and clinical crown length (CCL) were measured at each time point for analysis.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Clinical crown lengthening surgery
Phase 4

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Participants were recruited from patients who came for chief complaint of excess gingival display at the Dental Clinic of the Faculty of Odonto-stomatology, University of medicine and Pharmacy at Ho Chi Minh City. The study population included patients aged from eighteen years with an average length of excessive gingival display ≥ of 4 mm when maximum smiling (counted eight teeth, from the 14 to the 24 teeth) and the height of keratinized gingiva ≥ 3 mm.Participants were recruited from patients who came for chief complaint of excess gingival display at the Dental Clinic of the Faculty of Odonto-stomatology, University of medicine and Pharmacy at Ho Chi Minh City. The study population included patients aged from eighteen years with an average length of excessive gingival display ≥ of 4 mm when maximum smiling (counted eight teeth, from the 14 to the 24 teeth) and the height of keratinized gingiva ≥ 3 mm.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Effect of a Combination Between Clinical Crown Lengthening Surgery and Botulinum Toxin A Injection in Gummy Smile Treatment
Actual Study Start Date :
Aug 1, 2020
Actual Primary Completion Date :
May 31, 2021
Actual Study Completion Date :
May 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Subjects with gummy smile

The study procedure consisted of recruitment, pre&post-operative photography, gingivoplasty, BTX-A injection, recall visits, and data collecting.

Procedure: Clinical crown lengthening surgery
Clinical dental crown lengthening surgery protocol: a clinical crown lengthening surgery was performed. Post-operation protocol Patients were all prescribed antibiotics , anti-inflammation, analgesic, and an antiseptic mouthwash. Patients were instructed for oral hygiene and recalls. Botulinum Toxin A injection One hundred units (U) of botulinum toxin A (BTX-A) were diluted with 2.5ml of sterile saline solution without shaking. 1 mm syringe with a 30-gauge needle was used to get 0.25ml BTX-A for four-point injection, or 0.6ml in case injection of 6 points. Cold compress was applied extraoral 5 mins at injection site before injection. After local anesthesia, the doctor administered slowly 2,5 U of diluted BTX-A at each point until white cellulite appeared. Patients were recalled two weeks (T2), and two months (T3) after injection.
Other Names:
  • Botulinum toxin A injection
  • Outcome Measures

    Primary Outcome Measures

    1. Gingival exposure [At the time before treatment (T0)]

      The outcome is measured in millimeters based on photos of subjects included

    2. Gingival exposure [Two months after clinical crown lengthening surgery (T1)]

      The outcome is measured in millimeters based on photos of subjects included

    3. Gingival exposure [Two weeks after Botulinum toxin A injection (T2)]

      The outcome is measured in millimeters based on photos of subjects included

    4. Gingival exposure [Two months after Botulinum toxin A injection (T2)]

      The outcome is measured in millimeters based on photos of subjects included

    5. Clinical crown length [At the time before treatment (T0)]

      The clinical crown length is measured in millimeters using digital caliper and periodontal probe

    6. Clinical crown length [Two months after clinical crown lengthening surgery (T1)]

      The clinical crown length is measured in millimeters using digital caliper and periodontal probe

    7. Clinical crown length [Two weeks after Botulinum toxin A injection (T2)]

      The clinical crown length is measured in millimeters using digital caliper and periodontal probe

    8. Clinical crown length [Two months after Botulinum toxin A injection (T2)]

      The clinical crown length is measured in millimeters using digital caliper and periodontal probe

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Gummy smile because of 2 combined etiologies:

    • Short clinical crown of teeth due to the altered passive tooth eruption

    • Hyperactivity of upper lip muscles (lip mobility level > 8mm)

    Exclusion Criteria:
    • Pregnant or breastfeeding patients

    • Gummy smiles due to:

    • Maxillary bone overgrowth (maxillary hypertrophy)

    • Vertical maxillary excess

    • Neuromuscular disorder

    • Gingival hyperplasia due to medicine, supplements, or neuromuscular transmission inhibiting agents

    • Systematic diseases that can affect the result of surgical treatment (such as diabetes, heart disease taking blood anticoagulant medicament, blood diseases, immunodeficiency disease etc.)

    • Allergy to BTX-A or albumin

    • History of taking BTX-A injection in the head-neck area formerly

    • Patient with any contraindication of surgery

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Faculty of Odontostomatology - University of Medicine and Pharmacy at Ho Chi Minh City Ho Chi Minh City Vietnam 749000

    Sponsors and Collaborators

    • University of Medicine and Pharmacy at Ho Chi Minh City

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Nguyen Thu Thuy, Deputy Head of Department of Periodontology, University of Medicine and Pharmacy at Ho Chi Minh City
    ClinicalTrials.gov Identifier:
    NCT05057286
    Other Study ID Numbers:
    • 20338-DHYD
    First Posted:
    Sep 27, 2021
    Last Update Posted:
    Sep 27, 2021
    Last Verified:
    Sep 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    Yes
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    Yes
    Keywords provided by Nguyen Thu Thuy, Deputy Head of Department of Periodontology, University of Medicine and Pharmacy at Ho Chi Minh City
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 27, 2021